CASI Pharmaceuticals (CASIF) Total Non-Current Liabilities (2021 - 2026)
CASI Pharmaceuticals (CASIF) recorded Total Non-Current Liabilities of $11.15 million in Q2 2026, down 70.4% from $37.74 million a year earlier.
Powered by 
Analysis
CASI Pharmaceuticals (CASIF) Total Non-Current Liabilities (2021 - 2026) Analysis & Trends
At the end of FY2025, CASI Pharmaceuticals reported Total Non-Current Liabilities of $4.62 million, down 71.1% from FY2024.
- Annual Total Non-Current Liabilities has a four-year compound annual growth rate of -29.6% (FY2021 to FY2025).
- Across earlier years, Total Non-Current Liabilities came in at $15.96 million in FY2024 (-20.9%), $20.18 million in FY2023 (+24.3%), $16.23 million in FY2022 (-13.4%) and $18.75 million in FY2021.
- Quarterly Total Non-Current Liabilities has ranged from $4.62 million in Q4 2025 to $39.42 million in Q3 2025 over the past five years.
- On a year-over-year basis, Total Non-Current Liabilities rose in two of the last five quarters, with an average decline of 20.7%.
- Peak year-over-year performance for Total Non-Current Liabilities in the last five years was growth of 34.5% in Q2 2025, against a decline of 71.1% in Q4 2025 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 60.66 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 105.50 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 106.45 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 80.25 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 48.34 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 33.91 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 78.66 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 35.10 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 97.04 Bn |
| 10 | CASI Pharmaceuticals | 1.86 Mn | -18.97 Mn | - | 66.62 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 66.62 Mn |
| Dec 31, 2025 | 49.67 Mn |
| Sep 30, 2025 | 39.42 Mn |
| Jun 30, 2025 | 37.74 Mn |
| Mar 31, 2025 | 33.71 Mn |
| Dec 31, 2024 | 36.45 Mn |
| Jun 30, 2024 | 28.05 Mn |
| Mar 31, 2024 | 27.13 Mn |
| Dec 31, 2023 | 35.62 Mn |
| Sep 30, 2023 | 33.47 Mn |
| Jun 30, 2023 | 33.52 Mn |
| Mar 31, 2023 | 36.68 Mn |
| Dec 31, 2022 | 39.36 Mn |
| Dec 31, 2021 | 39.47 Mn |
API Access
CASI Pharmaceuticals Total Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=CASIF&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-non-current-liabilities", "ticker": "CASIF", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=CASIF&period=max&api_key=YOUR_API_KEY");
const data = await res.json();